Martin Dow

Martin Dow is a Pakistani multinational pharmaceutical company which is based in Karachi, Pakistan. It was founded in 1995[2] and is one of the largest pharmaceutical group in Pakistan. It has more than 60 brands and over 1000 employees. Its products are manufactured in Karachi at its cGMP compliant manufacturing plant.[3]

Martin Dow Ltd
IndustryPharmaceutical
Founded1995 (1995)
HeadquartersKarachi, Pakistan
Key people
Jawed Akhai
(Chairman)
ProductsDuvel Plus, CalOne-D, Musidin
Number of employees
1,000+ [1]
Websitewww.martindow.com
www.martindow.fr

Martin Dow has six manufacturing facilities in Pakistan.[4]

History

The company was founded in 1995.

In 2010, Martin Dow acquired the manufacturing facility and brands of Roche Pakistan.[5]

In 2015, Martin Dow was recognized as a Global Growth Company by the World Economic Forum.[6] In the same year, Martin Dow entered into an alliance with Biocodex S.A., a France-based pharmaceutical company.[7]

In 2016, German Merck KGaA executed a binding contract to divest its shareholding in Pakistan to Martin Dow Ltd.[8][9][10]

In 2016, in a €1.5 million deal, Martin Dow acquired the Bristol-Myers Squibb's pharmaceutical manufacturing facility in Meymac, France.[11][12] French President recently inaugurated Martin Dow Pharma Meymac Plant in France.[13] This plant was previously owned by Bristol-Myers Squibb[14]. The plant of V2Pharm in Gien was also taken over by Martin Dow.[15]

References
  1. "CORPORATE PROFILE". Martin Dow. Retrieved 31 December 2016.
  2. "Pakistani pharmaceutical company to operate in France". Business Recorder. 21 August 2016. Retrieved 30 December 2016.
  3. "Martin Dow - Corporate Profile".
  4. Hussain, Dilawar (21 November 2016). "A strategic relationship". Dawn newspaper. Retrieved 31 December 2016.
  5. "Martin Dow - Company Profile". Business Recorder. 15 July 2012. Retrieved 28 December 2016.
  6. "List of Global Growth Company Members" (PDF). World Economic Forum. Retrieved 30 December 2016.
  7. "Treating illness: Martin Dow, Biocodex ink alliance". Express Tribune. 12 March 2015. Retrieved 2 January 2017.
  8. "German pharma giant divests interests". The Express Tribune. PPI. 8 November 2016. Retrieved 28 December 2016.
  9. "Merck divests its Pakistan stake to Martin Dow". Dawn newspaper. 8 November 2016. Retrieved 28 December 2016.
  10. "Martin Dow acquires Merck operations in Pakistan". The News International. 8 November 2016. Retrieved 28 December 2016.
  11. "Pakistani pharmaceutical company to operate in France". Business Recorder. 21 August 2016. Retrieved 30 December 2016.
  12. Mérigaud, Corinne (3 December 2015). "Laboratoires Salem repris par le pakistanais Martin Dow". L'Usine Nouvelle. Retrieved 30 December 2016.
  13. "French President to inaugurate Pakistani Pharma Plant in France". Retrieved 3 January 2017.
  14. "Inauguration of Martin Dow plant by the French President (Meymac, 16 March 2017)". La France au Pakistan - Ambassade de France au Pakistan. Retrieved 1 April 2019.
  15. "L'ancien site de V2Pharm à Gien va être repris". 1 July 2015. Retrieved 3 January 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.